Antibacterial and osteogenic properties of silver-containing hydroxyapatite coatings produced using a sol gel process

Journal of Biomedical Materials Research - Part A

Volumn 82, Issue 4, 2007, Pages 899-906

  Chen, W ^a,b   Oh, S ^a   Ong, A P ^a   Oh, N ^c   Liu, Y ^d   Courtney, H S ^d   Appleford, M ^a,d   Ong, J L ^a  

^a The University of Texas at San Antonio   (United States)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c Inha University   (South Korea)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Bacterial adhesion; Hydroxyapatite; Osteoblast cell differentiation; Silver; Sol gel

Indexed keywords

BACTERIAL ADHESION; OSTEOBLAST CELL DIFFERENTIATION; STAPHYLOCOCCUS AUREUS;

BACTERIA; CELL PROLIFERATION; HYDROXYAPATITE; OSTEOBLASTS; SOL-GEL PROCESS; X RAY DIFFRACTION;

INORGANIC COATINGS;

ALKALINE PHOSPHATASE; HYDROXYAPATITE; SILVER; SILVER HYDROXYAPATITE; SILVER NITRATE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ADHERENCE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTACT ANGLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MESENCHYME CELL; OSTEOBLAST; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; X RAY DIFFRACTION;

ALKALINE PHOSPHATASE; ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; COATED MATERIALS, BIOCOMPATIBLE; DURAPATITE; EMBRYONIC STEM CELLS; GELS; HUMANS; MATERIALS TESTING; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOGENESIS; PROSTHESES AND IMPLANTS; SILVER; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; X-RAY DIFFRACTION;

EID: 34548190763     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31197     Document Type: Article

References (83)

1. Praemer A, Furner S, Rice DP. Musculoskeletal Conditions in the United States, 1st ed. Park Ridge, IL: American Academy of Orthopaedic Surgeons; 1992. p 27-41.
2. American Academy of Orthopaedic Surgeons studies feasibility of joint registry. J Am Acad Orthop Surg 2001;49:15-16.
3. Li PL, Zamora J, Bentley G. The results at ten years of the Insall-Burstein II total knee replacement: Clinical, radiological and survivorship studies. J Bone Joint Surg Br 1999;81:647-653.
4. Antti-Poika I, Josefsson G, Konttinen Y, Lidgren L, Santavirta S, Sanzen L. Hip arthroplasty infection: Current concepts. Acta Orthop Scand 1990;61:163-169.
5. Harris WH, Sledge CB. The total hip and total knee replacement (Part 11). N Engl J Med 1990;323:801-817.
6. Hanssen AD, Osmon DR, Nelson CL. Prevention of deep periprosthetic joint infection. Instr Course Lect 1997;46:555-567.
7. Nasser S. Prevention and treatment of sepsis in total hip replacement surgery. Orthop Clin North Am 1992;23:265-277.
8. Hendriks JGE. Van Horn JR, van der Mei HC, Busscher HJ. Backgrounds of antibiotic-loaded bone cement and prosthesis-related infection. Biomaterials 2004;25:545-556.
9. Stoodley P, Kathju S, Hu FZ, Erdos G, Levenson JE, Mehta N, Dice B, Johnson S, Hall-Stoodley L, Nistico L, Sotereanos N, Sewecke J, Post JC, Ehrlich GD. Molecular and imaging techniques for bacterial biofilms in joint arthroplasty infections. Clin Orthop Relat Res 2005;437:31-40.
10. Cen L, Neoh KG, Kang ET. Antibacterial activity of cloth functionalized with N-alkylated poly(4-vinylpyridine). J Biomed Mater Res A 2004;71:70-80.
11. Tiller JC, Liao CJ, Lewis K, Klibanov AM. Designing surfaces that kill bacteria on contact. Proc Natl Acad Sci USA 2001;98: 5981-5985.
12. Shi Z, Neoh KG, Kang ET, Wang W. Antibacterial and mechanical properties of bone cement impregnated with chitosan nanoparticles. Biomaterials 2006;27:2440-2449.
13. van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand 2001;72: 557-571.
14. Schmidmaier G, Lucke M, Wildemann B, Haas NP, Raschke M. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: A review. Injury 2006;37(Suppl 2):S105-S112.
15. Nohr RS, Macdonald JG. New biomaterials through surface segregation phenomenon: New quaternary ammonium compounds as antibacterial agents. J Biomater Sci Polym Ed 1994;5:607-619.
16. Tyagi M, Singh H. Preparation and antibacterial evaluation of urinary balloon catheter. Biomed Sci Instrum 1997;33:240-245.
17. Ewald A, Gluckermann SK, Thull R, Gbureck U. Antimicrobial titanium/silver PVD coatings on titanium. Biomed Eng Online 2006;5:22.
18. Bosetti M, Masse A, Tobin E, Cannas M. Silver coated materials for external fixation devices: in vitro biocompatibility and genotoxicity. Biomaterials 2002;23:887-892.
19. Chu CS, McManus AT, Pruitt BA Jr, Mason AD Jr. Therapeutic effects of silver nylon dressing with weak direct current on Pseudomonas aeruginosa-infected burn wounds. J Trauma 1988;28: 1488-1492.
20. Deitch EA, Marino AA, Malakanok V, Albright JA. Silver nylon cloth: In vivo and in vitro evaluation of antimicrobial activity. J Trauma 1987;27:301-304.
21. Marqraf HW, Covey TH Jr. A trial of silver-zinc-allantoinate in the treatment of leg ulcers. Arch Surg 1977;112:699-704.
22. Wyatt D, McGowan DN, Najarian MP. Comparison of a hydrocolloid dressing and silver sulfadiazine cream in the outpatient management of second-degree burns. J Trauma 1990;30:857-865.
23. Blaker JJ, Nazhat SN, Boccaccini AR. Development and characterisation of silver-doped bioactive glass-coated sutures for tissue engineering and wound healing applications. Biomaterials 2004;25: 1319-1329.
24. Bechert T, Steinrucke P, Guggenbichler JP. A new method for screening antibacterial biomaterials. Nat Med 2000;6:1053-1056.
25. Bechert T, Boswald M, Lugauer S, Regenfus A, Greil J, Guggenbichler JP. The Erlanger Silver Catheter: In vitro results for antimicrobial activity. Infection 1999;27(Suppl 11):S24-S29.
26. Joyce-Wohrmann RM, Munstedt H. Determination of the silver ion release from polyurethanes enriched with silver. Infection 1999;27(Suppl 1):S46-S48.
27. Alt V, Bechert T, Steinrucke P, Wagener M, Seidel P, Dingeldein E, Domann E, Schnettler R. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 2004;25:4383-4391.
28. Dueland R, Spadaro JA, Rahn BA. Silver antibacterial bone cement. Comparison with gentamicin in experimental osteomyelitis. Clin Orthop 1982;169:264-268.
29. Yang Y, Oh N, Liu Y, Chen W, Oh S, Appleford M, Kim S, Kim K, Park S, Bumgardner J, Haggard W, Ong J. Enhancing osseointegration using surface-modified titanium implants. J Oral Maxillofac Surg 2006;58:67-69.
30. Breme J, Steinhauser E, Paulus G. Commercially pure titanium Steinhauser plate-screw system for maxillofacial surgery. Biomaterials 1988;9:310-313.
31. Browne M, Greqson PJ. Effect of mechanical surface pretreatment on metal ion release. Biomaterials 2000;21:385-392.
32. Niinomi M. Fatigue performance and cyto-toxicity of low rigidity titanium alloy, Ti-29Nb-13Ta-4.6Zr. Biomaterials 2003,24:2673-2683.
33. Ong JL, Bessho K, Carnes DL. Bone response to plasma-sprayed hydroxyapatite and radiofrequency-sputtered calcium phosphate implants in vivo. Int J Oral Maxillofac Implants 2002;17: 581-586.
34. Yang Y, Kim K, Ong JL. A review on calcium phosphate coatings produced using a sputtering process - An alternative to plasma spraying. Biomaterials 2005;26:327-337.
35. McPherson EJ, Dorr LD, Gruen TA, Saberi MT. Hydroxyapatite-coated proximal ingrowth femoral stems. A matched pair control study. Clin Orthop Relat Res 1995;315:223-230.
36. Chung RJ, Hsieh MF, Huang CW, Perng LH, Wen HW, Chin TS. Antimicrobial effects and human gingival biocompatibility of hydroxyapatite sol-gel coatings. J Biomed Mater Res B Appl Biomater 2006;76:169-178.
37. Yang Y, Ong JL, Bessho K. Plasma-sprayed hydroxyapatite-coated and plasma-sprayed titanium-coated implants. In: Yaszemski MJ, Trantolo DJ, Lewandrowski KU, Hasirci V, Altobelli DE, Wise DL, editors. Biomaterials in Orthopedics. New York: Marcel Dekker; 2004. p 401-423.
38. Wang H, Eliaz N, Xiang Z, Hsu HP, Spector M, Hobbs LW. Early bone apposition in vivo on plasma-sprayed and electrochemically deposited hydroxyapatite coatings on titanium alloy. Biomaterials 2006;27:4192-4203.
39. Chen W, Liu Y, Courtney HS, Bettengaa M, Agrawalc CM, Bumgardner JD, Ong JL. In vitro anti-bacterial and biological properties of magnetron co-sputtered silver-containing hydroxyapatite coating. Biomaterials 2006;27:5512-5517.
40. Kim HW, Kim HE, Salih V, Knowles JC. Hydroxyapatite and titania sol-gel composite coatings on titanium for hard tissue implants; mechanical and in vitro biological performance. J Biomed Mater Res B Appl Biomater 2005;72:1-8.
41. Gross KA, Chai CS, Kannangara GS, Ben-Nissan B, Hanley L. Thin hydroxyapatite coatings via sol-gel synthesis. J Mater Sci Mater Med 1998;9:839-843.
42. Liu DM, Troczynski T, Tseng WJ. Water-based sol-gel synthesis of hydroxyapatite: Process development. Biomaterials 2001;22: 1721-1730.
43. Liu DP, Majewski P, O'Neill BK, Ngothai Y, Colby CB. The optimal SAM surface functional group for producing a biomimetic HA coating on Ti. J Biomed Mater Res A 2006;77:763-772.
44. Campbell AA, Fryxell GE, Linehan JC, Graff GL. Surface-induced mineralization: A new method for producing calcium phosphate coatings. J Biomed Mater Res 1996;32:111-118.
45. Liu DM, Yang Q, Troczynski T, Tseng WJ. Structural evolution of sol-gel-derived hydroxyapatite. Biomaterials 2002;23:1679-1687.
46. Liu DM, Yang Q, Troczynski T. Sol-gel hydroxyapatite coatings on stainless steel substrates. Biomaterials 2002;23:691-698.
47. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. II. Etiopathogenesis. Eur J Oral Sci 1998;106:721-764.
48. Flemming T, Renvert S. Consensus report: Maintenance and complications. In: Lang NP, Karring T, Lindhe J, editors. Proceeding of the 3rd European Workshop on Peridontology. Berlin: Quintessence Books; 1999. p 347-351.
49. Radin S, Campbell JT, Ducheyne P, Cuckler JM. Calcium phosphate ceramic coatings as carriers of vancomycin. Biomaterials 1997;18:777-782.
50. Korkusuz F, Uchida A, Shinto Y, Araki N, Inoue K, Ono K. Experimental implant-related osteomyelitis treated by antibiotic-calcium hydroxyapatite ceramic composites. J Bone Joint Surg Br 1993;75:111-114.
51. Shinto Y, Uchida A, Korkusuz F, Araki N, Ono K. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Joint Surg Br 1992;74:600-604.
52. Kim HW, Knowles JC, Kim HE. Porous scaffolds of gelatin-hydroxyapatite nanocomposites obtained by biomimetic approach: Characterization and antibiotic drug release. J Biomed Mater Res B Appl Biomater 2005;74:686-698.
53. Joosten U, Joist A, Gosheger G, Liljenqvist U, Brandt B, von Eiff C. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis. Biomaterials 2005;26:5251-5258.
54. Rauschmann MA, Wichelhaus TA, Stirnal V, Dingeldein E, Zichner L, Schnettler R, Alt V. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials 2005;26:2677-2684.
55. Benghuzzi HA, England BG, Bajpai PK. Controlled release of hydrophilic compounds by resorbable and biodegradable ceramic drug delivery devices. Biomed Sci Instrum 1992;28:179-182.
56. Peter B, Pioletti DP, Laib S, Bujoli B, Pilet P, Janvier P, Guicheux J, Zambelli PY, Bouler JM, Gauthier O. Calcium phosphate drug delivery system: Influence of local zoledronate release on bone implant osteointegration. Bone 2005;36:52-60.
57. Campbell AA, Song L, Li XS, Nelson BJ, Bottoni C, Brooks DE, Dejong ES. Development, characterization, and anti-microbial efficacy of hydroxyapatite-chlorhexidine coatings produced by surf ace-induced mineralization. J Biomed Mater Res 2000;53:400-407.
58. Uchida A, Shinto Y, Araki N, Ono K. Slow release of anticancer drugs from porous calcium hydroxyapatite ceramic. J Orthop Res 1992;10:440-445.
59. Otsuka M, Matsuda Y, Suwa Y, Fox JL, Higuchi WI. A novel skeletal drug delivery system using a self-setting calcium phosphate cement. V. Drug release behavior from a heterogeneous drug-loaded cement containing an anticancer drug. J Pharm Sci 1994;83: 1565-1568.
60. Cornell CN, Tyndall D, Waller S, Lane JM, Brause BD. Treatment of experimental osteomyelitis with antibiotic-impregnated bone graft substitute. J Orthop Res 1993;11:619-626.
61. Solberg BD, Gutowa AP, Baumgaertner MR. Efficacy of gentamycin- impregnated resorbable hydroxyapatite cement in treating osteomyelitis in a rat model. J Orthop Trauma 1999;13:102-106.
62. Shirtliff ME, Calhoun JH, Mader JT. Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite. Clin Orthop Relat Res 2002;401:239-247.
63. Yamamura K, Iwata H, Yotsuyanagi T. Synthesis of antibiotic-loaded hydroxyapatite beads and in vitro drug release testing. J Biomed Mater Res 1992;26:1053-1064.
64. Buranapanitkit B, Srinilta V, Ingviga N, Oungbho K, Geater A, Ovatlarnporn C. The efficacy of a hydroxyapatite composite as a biodegradable antibiotic delivery system. Clin Orthop Relat Res 2004;424:244-252.
65. Silver S. Bacterial silver resistance: Molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 2003; 27:341-353.
66. Jansen B, Rinck M, Wolbring P, Strohmeier A, Jahns T. In-vitro evaluation of the antimicrobial efficacy and biocompatibility of a silver-coated Central Venous Catheter. J Biomater Appl 1994;9: 55-70.
67. Bellantone M, Coleman NJ, Hench LL. Bacteriostatic action of a novel four-component bioactive glass. J Biomed Mater Res A 2000;51:484-490.
68. Hench DC, Hench LL. Bioactive response of Ag-doped tape cast Bioglass 45S5 following heat treatment. J Mater Sci Mater Med 2001;12:917-921.
69. Bellantone M, Williams HD, Hench LL. Broad-spectrum bactericidal activity of Ag(2)O-doped bioactive glass. Antimicrob Agents Chemother 2002;46:1940-1945.
70. Lansdown AB. Silver. I. Its antibacterial properties and mechanism of action. J Wound Care 2002;11:125-130.
71. Lansdown AB. Silver. II. Toxicity in mammals and how its products aid wound repair. J Wound Care 2002;11:173-177.
72. Lansdown AB, Sampson B, Laupattarakasem P, Vuttivirojana A. Silver aids healing in the sterile skin wound: Experimental studies in the laboratory rat. Br J Dermatol 1997;137:728-735.
73. Kramer SJ, Spadaro JA, Webster DA. Antibacterial and osteoinductive properties of demineralized bone matrix treated with silver. Clin Orthop Relat Res 1981;161:154-162.
74. Gristina AG. Biomaterial-centered infection: Microbial adhesion versus tissue integration. Science 1987;237:1588-1595.
75. Percival SL, Bowler PG, Russell D. Bacterial resistance to silver in wound care. J Hosp Infect 2005;60:1-7.
76. Guggenbichler JP, Boswald M, Lugauer S, Krall T. A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters. Infection 1999;27(Suppl 1): S16-S23.
77. Schreurs WJ, Rosenberq H. Effect of silver ions on transport and retention of phosphate by Escherichia coli. J Bacteriol 1982;152:7-13.
78. Bragg PD, Rainnie DJ. The effect of silver ions on the respiratory chain of Escherichia coli. Can J Microbiol 1974;20:883-889.
79. Russell AD, Huqo WB. Antimicrobial activity and action of silver. Prog Med Chem 1994;31:351-370.
80. An YH, Friedman RJ. Concise review of mechanisms of bacterial adhesion to biomaterial surfaces. J Biomed Mater Res 1998;43: 338-348.
81. Busscher HJ, Bos R, van der Mei HC. Initial microbial adhesion is a determinant for the strength of biofilm adhesion. FEMS Microbiol Lett 1995;128:229-234.
82. Gottenbos B, van der Mei HC, Busscher HJ. Initial adhesion and surface growth of Staphylococcus epidermidis and Pseudomonas aeruginosa on biomedical polymers. J Biomed Mater Res 2000;50: 208-214.
83. Bos R, van der Mei HC, Busscher HJ. Physico-chemistry of initial microbial adhesive interactions - Its mechanisms and methods for study. FEMS Microbiol Rev 1999;23:179-230.